Evidence map›Paper›PMID 30016401›Full record

ArticleCardiovascular research2019

Sex-specific regulation of collagen I and III expression by 17β-Estradiol in cardiac fibroblasts: role of estrogen receptors.

Elke Dworatzek, Shokoufeh Mahmoodzadeh, Cindy Schriever, Kana Kusumoto, Lisa Kramer, Gabriela Santos, Daniela Fliegner, Yuet-Kin Leung, Shuk-Mei Ho, Wolfram-Hubertus Zimmermann and 2 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Cardiovascular research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 119 citations in OpenAlex.

  1. CK2α Deficiency Drives Myocardial Fibrosis via Desmin-Induced Mitochondrial Dysfunction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Review
  3. Role ofInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Cardio-Vascular Extracellular Matrix: The Unmet Enigma.International journal of molecular sciences · 2026
    Review
  6. Review
  7. Article
  8. Age- and sex-specific physiological cardiac remodeling: the search for the Fountain of Youth.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Targeting Fibrosis in Right Ventricular Pressure Overload: Balancing on a Tightrope?American journal of respiratory cell and molecular biology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 2 countries.

Elke DworatzekCharité-Universitätsmedizin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Gender in Medicine, Center for Cardiovascular Research, Berlin, Germany.
Shokoufeh MahmoodzadehDZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Cindy SchrieverMax-Delbrueck-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Kana KusumotoCharité-Universitätsmedizin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Gender in Medicine, Center for Cardiovascular Research, Berlin, Germany.
Lisa KramerCharité-Universitätsmedizin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Gender in Medicine, Center for Cardiovascular Research, Berlin, Germany.
Gabriela SantosInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.
Daniela FliegnerPfizer Pharma GmbH, Berlin, Germany.
Yuet-Kin LeungDivision of Environmental Genetics and Molecular Toxicology, Department of Environmental Health, University of Cincinnati Medical Center, Cincinnati, OH, USA.
Shuk-Mei HoDivision of Environmental Genetics and Molecular Toxicology, Department of Environmental Health, University of Cincinnati Medical Center, Cincinnati, OH, USA.
Wolfram-Hubertus ZimmermannInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.
Susanne LutzInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.
Vera Regitz-ZagrosekCharité-Universitätsmedizin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Gender in Medicine, Center for Cardiovascular Research, Berlin, Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin · DEUniversitätsmedizin Göttingen · DEGerman Centre for Cardiovascular Research · DEHumboldt-Universität zu Berlin · DEMax Delbrück Center · DEPfizer (Germany) · DEUniversity of Cincinnati · USUniversity of Cincinnati Medical Center · US

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI YADAV, JAGJIT S · 1992 to 2022
$35.4M
PROSTATIC DIFFERENTIATION &SEX HORMONE METABOLISMR01CA015776 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HO, SHUK-MEI · 1987 to 2008
$1.8M
Estrogen Receptor-beta and Prostate FunctionR01DK061084 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HO, SHUK-MEI · 2001 to 2004
$1.2M
NCI NIH HHS R01 CA015776NIDDK NIH HHS R01 DK061084NIEHS NIH HHS P30 ES006096
6 · The paper itself

Abstract

Aims: Sex differences in cardiac fibrosis point to the regulatory role of 17β-Estradiol (E2) in cardiac fibroblasts (CF). We, therefore, asked whether male and female CF in rodent and human models are differentially susceptible to E2, and whether this is related to sex-specific activation of estrogen receptor alpha (ERα) and beta (ERβ). Methods and results: In female rat CF (rCF), 24 h E2-treatment (10-8  M) led to a significant down-regulation of collagen I and III expression, whereas both collagens were up-regulated in male rCF. E2-induced sex-specific collagen regulation was also detected in human CF, indicating that this regulation is conserved across species. Using specific ERα- and ERβ-agonists (10-7 M) for 24 h, we identified ERα as repressive and ERβ as inducing factor in female and male rCF, respectively. In addition, E2-induced ERα phosphorylation at Ser118 only in female rCF, whereas Ser105 phosphorylation of ERβ was exclusively found in male rCF. Further, in female rCF we found both ER bound to the collagen I and III promoters using chromatin immunoprecipitation assays. In contrast, in male rCF only ERβ bound to both promoters. In engineered connective tissues (ECT) from rCF, collagen I and III mRNA were down-regulated in female ECT and up-regulated in male ECT by E2. This was accompanied by an impaired condensation of female ECT, whereas male ECT showed an increased condensation and stiffness upon E2-treatment, analysed by rheological measurements. Finally, we confirmed the E2-effect on both collagens in an in vivo mouse model with ovariectomy for E2 depletion, E2 substitution, and pressure overload by transverse aortic constriction. Conclusion: The mechanism underlying the sex-specific regulation of collagen I and III in the heart appears to involve E2-mediated differential ERα and ERβ signaling in CFs.

Indexed as

AgedAnimalsBinding SitesCells, CulturedCollagen Type ICollagen Type IIIDisease Models, AnimalEstradiolEstrogen Receptor alphaEstrogen Receptor betaEstrogensFemaleFibroblastsFibrosisHeart DiseasesHumansCollagen Type ICollagen Type IIIEstradiolestradiol 3-benzoateEstrogen Receptor alphaEstrogen Receptor betaEstrogensReceptors, Estrogen

Identifiers

PMID30016401
PMCPMC6933535
OpenAlexW2884514580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.